| | | | | | | | | | |
|
|
| Dockets Entered
On January 4, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim 'Healthy' & Health Claims
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2001D-0059
|
| Submitting Clinical Data for Purposes of Assessing User Fees
|
|
|
| 2003D-0117
|
| Implementation of Inspection by Accredited Persons Program
|
|
|
| 2003P-0564
|
| 513(f) Reclassification Petition for In Vitro Diagnostics for Anti-Hepatitis A Virus IgM and Total Antibodies
|
|
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
| 2004D-0377
|
| International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
|
|
|
| 2004D-0385
|
| Class II Special Controls Guidance Document: Hepatitis A Serological Assays for the Clinical Laboratory Diagnosis of Hepatitis A Virus
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
| 2004D-0459
|
| Guidance for Industry on Pharmacokinetics in Pregnancy Study Design, Data Analysis, and Impact on Dosing and Labeling
|
|
|
| 2004D-0493
|
| Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
|
|
|
| 2004D-0494
|
| Guidance for Industry on Changes to an Approved NDA or ANDA; Specifications Use of Enforcement Discretion for Compendial Changes
|
|
|
| 2004D-0510
|
| Live & Perishable Fish & Fishery Products for Export to the European Union and the European Free Trade Association
|
|
|
| 2004N-0296
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Good Laboratory Practice (GLP) Regulations for Nonclinical Studies (21 CFR Part 58)
|
|
|
| 2004N-0416
|
| Beverages: Bottled Water
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
|
| 2004N-0458
|
| Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
|
|
|
| 2004N-0461
|
| Amendment to 25.34; Categorical Exclusions Environmental Assessment
|
|
|
| 2004N-0480
|
| The Minor Use & Minor Species (MUMS) Animal Health Act
|
|
|
| 2004N-0503
|
| Agency Information Collection Activities: Proposed Collection; Comment Request: Guidance on Consultation Procedures; Foods Derived From New Plant Varieties
|
|
|
| 2004N-0516
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey
|
|
|
| 2004N-0526
|
| Agency Information Collection Activities; Proposed Collection; Comment Request;
|
|
|
| 2004N-0534
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Format and Content Requirements for Over-The Counter (OTC) Drug Product Labeling
|
|
|
| 2004N-0539
|
| Establishing a Docket for the Development of Plasma Standards Public Workshop; Availability
|
|
|
| 2004N-0554
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Irradiation in the Production, Processing and Handling of Food
|
|
|
| 2004P-0472
|
| refuse final approval to ANDA 76-258 for a generic fentanyl transdermal lsystem under it current proposed labeling
|
|
|
| 1995P-0241
|
| Implied Nutrient Content Claim 'Healthy' & Health Claims
|
|
|
| EC 1
|
| CHF patients
|
| Vol #:
|
| 9
|
|
|
| EC
3
|
| American Bakers Association
|
| Vol #:
|
| 9
|
|
|
| EC
4
|
| Grocery Manufacturers of America
|
| Vol #:
|
| 9
|
|
|
| 1995S-0316
|
| 75-Day Premarket Notifications for New Dietary Ingredients
|
|
|
| RPT
255
|
| Antanais Corp. (Suisse) SA
|
| Vol #:
|
| 174
|
|
|
| RPT
256
|
| Natursol
|
| Vol #:
|
| 187
|
|
|
| RPT
257
|
| Natursol
|
| Vol #:
|
| 188
|
|
| | | | | | | | |
|
|
| EMC 422
|
| D. Steinberg
|
| Vol #:
|
| 8
|
|
|
| EMC 423
|
| M. O'Neal
|
| Vol #:
|
| 8
|
|
|
| EMC 424
|
| M. Ravina
|
| Vol #:
|
| 8
|
|
|
| EMC 425
|
| S. Hannah
|
| Vol #:
|
| 8
|
|
|
| EMC 426
|
| G. Sindelar
|
| Vol #:
|
| 8
|
|
|
| EMC 427
|
| R. Caloggero
|
| Vol #:
|
| 8
|
|
|
| EMC 428
|
| P. Drew
|
| Vol #:
|
| 8
|
|
|
| EMC 429
|
| Form Letters
|
| Vol #:
|
| 9
|
|
|
| 2004D-0377
|
| International Conference on Harmonisation; Draft Guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
|
|
|
|
|
|
| EMC
1
Attachment
|
| Johnson & Johnson Pharmaceutical Research & Development, LLC
|
| Vol #:
|
| 1
|
|
|
| 2004D-0385
|
| Class II Special Controls Guidance Document: Hepatitis A Serological Assays for the Clinical Laboratory Diagnosis of Hepatitis A Virus
|
|
|
| EC
2
|
| AdvaMed
|
| Vol #:
|
| 1
|
|
|
| 2004D-0440
|
| Guidance for Industry on Computerized Systems Used in Clinical Trials
|
|
|
| EC
5
|
| ClinPhone
|
| Vol #:
|
| 1
|
|
|
| EC
6
|
| Data Quality Research Institute
|
| Vol #:
|
| 1
|
|
|
| EC
7
|
| PHT Corporation
|
| Vol #:
|
| 1
|
|
|
| EMC
3
|
| Merck & Co., Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004D-0459
|
| Guidance for Industry on Pharmacokinetics in Pregnancy Study Design, Data Analysis, and Impact on Dosing and Labeling
|
|
|
| EMC
1
|
| Merck & Co., Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004D-0493
|
| Draft Guidance for Industry on Recommended Approaches to Integration of Genetic Toxicology Study Results
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004D-0494
|
| Guidance for Industry on Changes to an Approved NDA or ANDA; Specifications Use of Enforcement Discretion for Compendial Changes
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004D-0510
|
| Live & Perishable Fish & Fishery Products for Export to the European Union and the European Free Trade Association
|
|
|
| EC 2
|
| Stavis Seafoods, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0296
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Good Laboratory Practice (GLP) Regulations for Nonclinical Studies (21 CFR Part 58)
|
|
|
| N
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0416
|
| Beverages: Bottled Water
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 2
|
|
|
| 2004N-0454
|
| Dietary Supplements; Premarket Notification for New Dietary Ingredient Notifications; Public Meeting
|
|
| | | | | | | | |
|
|
| EMC
6
|
| BASF Corporation
|
| Vol #:
|
| 3
|
|
|
| 2004N-0458
|
| Dietary Supplements; Regulatory Strategy for the Further Implementation and Enforcement of the Dietary Supplement Health and Education Act of 1994
|
|
|
| EC 8
|
| Dr. edmund copeland
|
| Vol #:
|
| 1
|
|
|
| 2004N-0461
|
| Amendment to 25.34; Categorical Exclusions Environmental Assessment
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004N-0480
|
| The Minor Use & Minor Species (MUMS) Animal Health Act
|
|
|
| EC 1
|
| Michigan State University - Sheep Extension Veteri
|
| Vol #:
|
| 1
|
|
|
| 2004N-0503
|
| Agency Information Collection Activities: Proposed Collection; Comment Request: Guidance on Consultation Procedures; Foods Derived From New Plant Varieties
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004N-0516
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; 2005 Food Safety Survey
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004N-0526
|
| Agency Information Collection Activities; Proposed Collection; Comment Request;
|
|
|
| EC 1
|
| Ms. Barabara Sachau
|
| Vol #:
|
| 1
|
|
|
| 2004N-0534
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Format and Content Requirements for Over-The Counter (OTC) Drug Product Labeling
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0539
|
| Establishing a Docket for the Development of Plasma Standards Public Workshop; Availability
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004N-0554
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Irradiation in the Production, Processing and Handling of Food
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004P-0472
|
| refuse final approval to ANDA 76-258 for a generic fentanyl transdermal lsystem under it current proposed labeling
|
|
|
| EMC
1
|
| Noven Pharmaceuticals, Inc. (Noven)
|
| Vol #:
|
| 2
|
|